Related Experiment Video
Updated: Oct 25, 2025

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
Higher Ventricular-Arterial Coupling Derived from Three-Dimensional Echocardiography Is Associated with a Worse
Francesco Tona1, Elisabetta Zanatta2, Roberta Montisci3
1Department of Cardiac, Thoracic, Vascular Sciences and Public Health, 35128 Padova, Italy.
Insights
Systemic sclerosis (SSc) patients may have impaired ventricular-arterial coupling (VAC) even without overt heart disease. Higher VAC predicts a greater risk of major adverse cardiovascular events (MACE) in SSc.
Area of Science:
- Cardiology
- Rheumatology
- Biomedical Engineering
Background:
- Primary myocardial involvement is frequent in systemic sclerosis (SSc).
- Ventricular-arterial coupling (VAC) is crucial for cardiovascular (CV) performance, linking ventricular function and arterial load.
- Altered VAC may precede detectable cardiac dysfunction in SSc.
Purpose of the Study:
- To investigate VAC and related indices in SSc patients without primary myocardial involvement.
- To explore the association between altered VAC and survival free from major adverse CV events (MACE) in SSc.
Main Methods:
- Cross-sectional study comparing 65 SSc patients (without cardiac evidence) to healthy controls.
- Three-dimensional echocardiography (3DE) for noninvasive measurement of end-systolic elastance (Ees), arterial elastance (Ea), and VAC (Ea/Ees).
- Median 4-year follow-up for MACE (death/hospitalization).
Main Results:
- SSc patients exhibited higher Ees, Ea, and end-diastolic elastance (Eed) than controls, with similar VAC.
- Diffuse cutaneous SSc (dcSSc) showed lower Ees and higher VAC compared to limited cutaneous SSc (lcSSc).
- VAC > 0.63 was associated with a 2.5-fold increased risk of MACE and reduced event-free survival (p=0.005).
Conclusions:
- Ventricular-arterial coupling may be subtly impaired in SSc patients even before clinical signs of cardiac involvement.
- VAC serves as a potential prognostic biomarker for cardiovascular events in systemic sclerosis.
Abstract:
Primary myocardial involvement is common in systemic sclerosis (SSc). Ventricular-arterial coupling (VAC) reflecting the interplay between ventricular performance and arterial load, is a key determinant of cardiovascular (CV) performance. We aimed to investigate VAC, VAC-derived indices, and the potential association between altered VAC and survival free from death/hospitalization for major adverse CV events (MACE) in scleroderma. Only SSc patients without any anamnestic and echocardiographic evidence of primary myocardial involvement who underwent three-dimensional echocardiography (3DE) were included in this cross-sectional study and compared with healthy matched controls. 3DE was used for noninvasive measurements of end-systolic elastance (Ees), arterial elastance (Ea), VAC (Ea/Ees) and end-diastolic elastance (Eed); the occurrence of death/hospitalization for MACE was recorded during follow-up. Sixty-five SSc patients (54 female; aged 56 ± 14 years) were included. Ees (p = 0.04), Ea (p = 0.04) and Eed (p = 0.01) were higher in patients vs. controls. Thus, VAC was similar in both groups. Ees was lower and VAC was higher in patients with diffuse cutaneous form (dcSSc) vs. patients with limited form (lcSSc) (p = 0.001 and p = 0.02, respectively). Over a median follow-up of 4 years, four patients died for heart failure and 34 were hospitalized for CV events. In patients with VAC > 0.63 the risk of MACE was higher (HR 2.5; 95% CI 1.13-5.7; p = 0.01) and survival free from death/hospitalization was lower (p = 0.005) than in those with VAC < 0.63. Our study suggests that VAC may be impaired in SSc patients without signs and symptoms of primary myocardial involvement. Moreover, VAC appears to have a prognostic role in SSc.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Heart Failure III: Clinical Manifestations
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...

